Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/27/2003WO2002081498A3 Novel proteins and nucleic acids encoding same
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
11/27/2003WO2002077030A3 Modified mhc molecules whose binding to cd8 or cd4 is inhibited and use thereof
11/27/2003WO2002072865A3 Methods, kits and compositions of combination oligomers
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070668A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/27/2003WO2002070647A8 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
11/27/2003WO2002070019A8 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2002048341A3 Knockout mice for a2d2 calcium ion channel subunit proteins
11/27/2003WO2002046424A3 Fibroblast growth factors
11/27/2003WO2002040662A3 Transgenic mice containing targeted gene disruptions
11/27/2003WO2001064875A9 Human transporter genes and proteins encoded thereby
11/27/2003US20030221224 Improving plant reproduction, propagation and yields via control of silk receptivity to pollen
11/27/2003US20030221223 Producing genetically engineerered human blood protein such as hemoglobin, antitrypsin, fibrinogen and thrombin in monocot plant seed; veterinary medicine
11/27/2003US20030221222 Plant retroviral polynucleotides and methods for use thereof
11/27/2003US20030221221 Preparing transgenic plant with increased growth rate, flowers and seed yield
11/27/2003US20030221218 Bioengineering cotton fiber properties
11/27/2003US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants
11/27/2003US20030221214 Citrus tristeza virus resistance genes and methods of use
11/27/2003US20030221213 Using endogenous genetic elements to genetically enhance nutritional value and agronomic performance of plant without permanent or stable incorporation of unknown or foreign DNA into genome; reduction of freeze induced sweetening
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030221204 BRI constructs and methods of using
11/27/2003US20030221201 Comprises chimeric transferrin-glucogon like polypeptide with reduced glycosylation, metal binding and receptor recognition for treatment and prevntion of multiple sclerosis, cancer and viral diseases
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220491 Novel human transporter proteins and polynucleotides encoding the same
11/27/2003US20030220490 Cell membrane directed drugs
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220488 Comprises peptide for diagnosing and treating cancer, hypoxia, blood and immunological disorders
11/27/2003US20030220487 Flea peritrophin nucleic acid molecules, proteins and uses thereof
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220482 Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220479 Comprises g-protein coupled receptor polypeptide for use in discovering modulators of taste, odors and pheromone response
11/27/2003US20030220478 Novel compounds
11/27/2003US20030220477 G-protein coupled receptors
11/27/2003US20030220476 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent
11/27/2003US20030220475 Neutralizing immunogenic hev polypepetides
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220285 Expression vectors for stimulating an immune response and methods of using the same
11/27/2003US20030220276 HIV vaccine and method of use
11/27/2003US20030220274 Plasmid comprising a chicken beta actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (p beta GLP1), carrying a furin cleavage site
11/27/2003US20030220263 Treating, diagnosing, preventing, and screening for disorders associated with aberrant cell growth, neurological conditions, and diseases or disorders related to the brain
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220255 GLP-1 agonist and cardiovascular complications
11/27/2003US20030220249 Genes, related nucleic acids, their complements, polypeptides
11/27/2003US20030220248 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
11/27/2003US20030220246 Novel FGF homolog zFGF11
11/27/2003US20030220243 A 37 amino acid peptide that is secreted by the L-cells of the intestine in response to food ingestion, because of their ability to stimulate insulin secretion, can be used for the treatment of diabetes, obesity and releated conditions
11/27/2003US20030220240 Vesicle trafficking proteins
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220235 Muteins of the CGRP 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
11/27/2003US20030220233 Radiolabeled annexins
11/27/2003US20030220231 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
11/27/2003US20030220230 Enhancement of iron chelation therapy
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219897 A vector for transfecting a plant cell, obtained from a tomato mosaic virus, a tobacco masaic virus, producing an antisense RNA or a suppressor RNA, for inhibiting or reducing of gene expression
11/27/2003US20030219886 Directed evolution of novel binding proteins
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219869 Expression of recombinant human proteins in Tetrahymena
11/27/2003US20030219868 Comprises nucleotide sequences coding g-protein coupled receptor for diagnosing and/or treating behavioral or physiological disorders; drug screening
11/27/2003US20030219865 Comprises nucleotide sequences coding proteins which are expressed at low temperatures; model system for studying cold adaptation
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219863 Soluble CTLA4 mutant molecules and uses thereof
11/27/2003US20030219862 Comprises polypeptides for treating diabetes, cell proliferative, tumor, nervous system, hypertensive, hypotensive, nervous system and eating disorder
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219859 Preparing viral protein 22 (VP22) for use as gene therapeutic tool in treatment of cancer; drug delivery
11/27/2003US20030219858 Novel heteromultimeric ion channel receptor and uses thereof
11/27/2003US20030219857 Preparing protein cross-linking enzymes for use in food processing and drug delivevry
11/27/2003US20030219856 Comprises nucleotide sequences coding chimeric membrane proteins for diagnosing and treating cancer; antiproliferative/antitumor/antiinflammatory agents
11/27/2003US20030219855 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/27/2003US20030219854 Methods for producing modified anti-infective peptides
11/27/2003US20030219853 Method of cross-linking a compound
11/27/2003US20030219852 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions
11/27/2003US20030219851 Preparing mucin-type glycopeptides using transglycosylation activity of N-acetylgalactosaminidase
11/27/2003US20030219846 Assay for activity of the ActRIIB kinase
11/27/2003US20030219834 Identifying modulator of cold sensation and pain; drug screening; cancer diagnosis
11/27/2003US20030219830 Preparing polysaccharide conjugated glycoproteins for use as drug delivery tools in human therapeutics
11/27/2003US20030219823 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/27/2003US20030219814 Novel fluorescent proteins
11/27/2003US20030219813 Identification of a family of secreted proteins in vascular endothelium
11/27/2003US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
11/27/2003US20030219799 Cancer-linked gene as target for chemotherapy
11/27/2003US20030219793 High bone mass gene of 11q13.3
1 ... 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 ... 2916